Suppr超能文献

一种用于生长抑素受体显像的高亲和力18F-三氟硼酸奥曲肽衍生物的临床前评估。

Preclinical evaluation of a high-affinity 18F-trifluoroborate octreotate derivative for somatostatin receptor imaging.

作者信息

Liu Zhibo, Pourghiasian Maral, Bénard François, Pan Jinhe, Lin Kuo-Shyan, Perrin David M

机构信息

Chemistry Department, University of British Columbia, Vancouver, British Columbia, Canada; and.

BC Cancer Agency Research Centre, Vancouver, British Columbia, Canada.

出版信息

J Nucl Med. 2014 Sep;55(9):1499-505. doi: 10.2967/jnumed.114.137836. Epub 2014 Jun 26.

Abstract

UNLABELLED

Recent studies have highlighted the high sensitivity of PET imaging with (68)Ga-labeled octreotide derivatives for the detection and staging of neuroendocrine tumors. A somatostatin receptor ligand that is easily radiolabeled with (18)F-fluoride could improve the availability of PET imaging of neuroendocrine tumors. We report an alkyltrifluoroborate-octreotate conjugate that is radiolabeled in a 1-step (18)F exchange reaction in high yield and with high specific activity.

METHODS

We conjugated a new alkyltrifluoroborate to octreotate to obtain AMBF3-TATE, which was stored in 50-nmol aliquots for radiolabeling. (18)F labeling was performed by (18)F-(19)F isotope exchange with (18)F-fluoride, and the tracer was purified by C18 cartridge separation. The radiochemical yield was 20%-25%. PET imaging and biodistribution were performed on mice bearing AR42J tumor xenografts.

RESULTS

AMBF3-TATE bound the somatostatin receptor subtype 2 with high affinity (inhibition constant, 0.13 ± 0.03 nM). Starting with 29.6-37 GBq (0.8-1 Ci) of (18)F-fluoride, more than 7.4 GBq (>200 mCi) of (18)F-AMBF3-TATE were obtained in 25 min (n = 5) with greater than 99% radiochemical purity at high specific activity (>111 GBq [3 Ci]/μmol). (18)F-AMBF3-TATE was stable in plasma. PET imaging and biodistribution showed rapid renal excretion with low liver activity. High tumor uptake (10.11% ± 1.67% injected dose/g, n = 5) was detected at 60 min after injection. Bone uptake was negligible. Tumor-to-liver, tumor-to-blood, tumor-to-muscle, and tumor-to-bone ratios (at 60 min) were 26.2 ± 0.8, 25.1 ± 1.0, 89.0 ± 3.1, and 21.3 ± 3.6, respectively.

CONCLUSION

(18)F-AMBF3-TATE was radiolabeled in high yield and at high specific activity, did not require high-performance liquid chromatography purification, exhibited unexpectedly high binding affinity to somatostatin receptor subtype 2, and showed excellent pharmacokinetic properties in vivo, with high tumor uptake and high contrast ratios.

摘要

未标记

近期研究强调了使用(68)Ga标记的奥曲肽衍生物进行PET成像对神经内分泌肿瘤检测和分期具有高敏感性。一种易于用(18)F-氟化物进行放射性标记的生长抑素受体配体可提高神经内分泌肿瘤PET成像的可用性。我们报告了一种烷基三氟硼酸盐-奥曲肽共轭物,其在一步(18)F交换反应中以高产率和高比活进行放射性标记。

方法

我们将一种新的烷基三氟硼酸盐与奥曲肽共轭以获得AMBF3-TATE,将其以50 nmol的分装量储存用于放射性标记。通过与(18)F-氟化物进行(18)F-(19)F同位素交换进行(18)F标记,并通过C18柱分离纯化示踪剂。放射化学产率为20%-25%。对携带AR42J肿瘤异种移植物的小鼠进行PET成像和生物分布研究。

结果

AMBF3-TATE以高亲和力结合生长抑素受体2亚型(抑制常数,0.13±0.03 nM)。从29.6-37 GBq(0.8-1 Ci)的(18)F-氟化物开始,在25分钟内获得了超过7.4 GBq(>200 mCi)的(18)F-AMBF3-TATE(n = 5),在高比活(>111 GBq [3 Ci]/μmol)下放射化学纯度大于99%。(18)F-AMBF3-TATE在血浆中稳定。PET成像和生物分布显示肾脏快速排泄且肝脏活性低。注射后60分钟检测到高肿瘤摄取(10.11%±1.67%注射剂量/克,n = 5)。骨摄取可忽略不计。肿瘤与肝脏、肿瘤与血液、肿瘤与肌肉以及肿瘤与骨的比值(60分钟时)分别为26.2±0.8、25.1±1.0、89.0±3.1和21.3±3.6。

结论

(18)F-AMBF3-TATE以高产率和高比活进行放射性标记,无需高效液相色谱纯化,对生长抑素受体2亚型表现出出乎意料的高结合亲和力,并且在体内显示出优异的药代动力学特性,具有高肿瘤摄取和高对比度。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验